1 The abbreviations used are: IAP, inhibitors of apoptosis; BIR, baculoviral IAP repeat; NO, nitric oxide; MAP, mitogen-activated protein; SNAP, S-nitroso-N-acetyl-penicillamine; SNP, sodium nitroprusside; cPTIO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide; PBS, phosphate-buffered saline; MTT, 3-(4,5-dimethyl-thiazol-2-yl) 2,5-diphenyl tetrazolium bromide; FITC, fluorescein isothiocyanate; PI, propidium iodide. 
INTRODUCTION
Survivin is expressed in the embryo stage and most human tumor cells, but it is undetectable in normal adult cells (1) (2) (3) . The gene map position of survivin is located on the 17q25 of chromosome, and is expressed as a 16.5-kDa protein (1, 4, 5) . Survivin is a member of the inhibitors of apoptosis (IAP) 1 family (6,7) that contains a single zinc-binding motif, called baculoviral IAP repeat (BIR) (4, 8, 9) . The homology of survivin to IAP has been demonstrated by the observation that exhibits anti-apoptotic activity and inhibits the activity of caspases (4, 5, 9, 10) . In addition, survivin has been shown to maintain the integrity of microtubule (2, 11) , which is expressed at the G 2 /M transition stage and concentrates on the mitotic spindle (1) (2) (3) 12) . Moreover, the inhibition of survivin has been found to correlate with the cell cycle defects (2, 3, 13) . The survivin activity resulted from the phosphorylation of Thr-34 by the mitotic kinase complex cdc2/cyclin B1 (3, 10) . However, the precise mechanism of the regulation of survivin gene and protein expression of the cancer cells is still not clear.
Nitric oxide (NO) is an important signaling messenger that has been shown to play important roles in many physiological and pathological conditions (14) (15) (16) . Endogenous NO is generated from L-arginine by three major types of NO synthase (NOS), i.e., endothelial NOS (eNOS), neural NOS (nNOS), and inducible NOS (iNOS) (17, 18) . It has been shown that NO can induce apoptosis in a variety of tumor cells (19, 20) . NO triggers apoptosis by mechanisms involving induction of stress proteins, mitochondrial disruption, release of cytochrome c, and caspase activation (21) (22) (23) (24) (25) . In a recent study, NO has been shown to induce an increase in protein levels of p21 and a G 2 /M cell cycle checkpoint (26) . The p38 mitogen-activated protein (MAP) kinase pathway can mediate the cell growth arrest and apoptosis in response to different stimuli (27) (28) (29) . It has been found that the p38 MAP kinase mediates NO-induced apoptosis (29) (30) (31) . The specific inhibitor of p38 MAP kinase, SB203580, can inhibit the iNOS mRNA expression and the NO production in macrophages (30) . Furthermore, p38 MAP kinase regulates NO-induced apoptosis that associates with the p53 accumulation and the caspase-3 activation in chondrocytes (29) .
In this study, we investigated the expression and regulation of survivin in the NO-induced cell growth inhibition and apoptosis in the human lung cancer cells and its possible mechanisms. We further studied the role of p38 MAP kinase in the survivn expression on cell survival of the NO-exposed cells. Using NO donors or transfection of an iNOS expression vector, we found that the survivin expression in the lung carcinoma cells was down-regulated via the p38 MAP kinase pathway, and may involve the inhibition of cdc2/cyclin B1 complex. Cell culture-The A549 cell line was derived from human lung carcinoma of a 58-year-old Caucasian male (32) . The H1299 cell line was p53-null and was derived from a non-small cell lung adenocarcinoma tumor (33, 34) . The CL3 cell line, from a non-small-cell lung adenocarcinoma tumor of a 60-year-old male patient in Taiwan, was established by Dr. P. C.
EXPERIMENAL PROCEDURES

Chemicals and Antibodies-Cpd
Yang of the National Taiwan University Hospital (35 Technologies, Grand Island, NY) supplemented with 100 units/ml penicillin, 100 µg/ml streptomycin, L-glutamine (0.03%, w/v), sodium bicarbonate (2.2%, w/v), and 10% fetal bovine serum (FBS). The cells were maintained at 37°C and 5% CO 2 in a humidified incubator (310/Thermo, Forma Scientific, Inc., Marietta, Ohio).
Cytotoxicity Assay-The cells were plated in 96-well plates at a density of 1 × 10 4 cells/well for 16-20 h. Then, the cells were treated with 0-0.8 mM SNAP or 0-2 mM SNP for 24 h in serum-free RPMI-1640 medium. Following drug treatment, the cells were washed twice with phosphate-buffered saline (PBS), and were cultured in complete RPMI-1640 medium (containing 10% serum) for 2 days. Subsequently, the medium was replaced and the cells were treated with 500 µg/ml of 3-(4,5-dimethyl-thiazol-2-yl) 2,5-diphenyl tetrazolium bromide (MTT) (Sigma) in complete RPMI-1640 medium for 4 h. The surviving cells converted MTT to formazan that generates a blue-purple color when dissolved in dimethyl sulfoxide (DMSO) (37) . The intensity was measured at 545 nm using a plate reader for enzyme-linked immunosorbent assays. The absorbance of each treatment was from the average of 6 repeats (wells). The relative percentage of survival was calculated by dividing the absorbance of treatment by that of the control in each experiment.
Apoptosis Assay-The adherent cells were cultured on coverslips. After exposure to SNAP (0.4 mM, 24 h), the cells were washed twice with isotonic PBS (pH 7.4). Annexin V-fluorescein isothiocyanate (FITC) binding assay kit (Strong Biotech, Taipei, Taiwan) was used for the examination of apoptosis. The cells were stained with annexin V-FITC in binding buffer containing propidium iodide (PI) for 30 min in the dark. Then, the cells were washed three times with isotonic PBS (pH 7.4) and analyzed using fluorescence microscope.
During the apoptotic process, the enrichment of mono-and oligonucleosomes in cytoplasm of the apoptotic cell is due to DNA degradation prior to plasma membrane breakdown (38) .
The Cell Death Detection ELISA plus kit (Roche Molecular Biochemicals, Mannheim, Germany) was based on the quantitative sandwich enzyme-immunoassay using antibodies NO Production Assay-NO production was detected by measuring the stable NO metabolite, nitrite, in cultured medium using a spectrophotometric method based on the Griess reaction (39) . After exposure to SNAP or SNP, the 100 µl culture supernatant was mixed with 100 µl of Griess reagent (0.1% naphthyl ethylenediamine dihydrochloride, 1%
sulfanilamide, and 1.25% H 3 PO 4 ). Following incubation for 5-10 min at room temperature, nitrite concentrations were measured at 550 nm using a plate reader for enzyme-linked immunosorbent assays.
Cell Cycle Analysis-Asynchronized-CL3 and -H1299 cells were plated at a density of 1. Chalfont Buckinghamshire, England) in PBS containing 0.25% Triton X-100 and 10%
normal goat serum for 3 h at 37℃, and washed three times with 0.25% Triton X-100 in PBS.
The nuclei were stained with 2.5 µg/ml Hoechst 33258 (Sigma) for 10 min. Finally, the samples were stored in the dark at 4°C until examined under a fluorescence microscope. The images were digitally processed for presentation by Adobe Photoshop software (Ver. 6.0), Adobe Systems (San Jose, CA). Western Blot Analysis-Western analyses of Bcl-2, cdc2, phospho-cdc2, cyclin B1, ERK-2, p38, phospho-p38, survivin, and XIAP were performed using specific antibodies. Cells were lysed in the ice-cold cell extraction buffer (pH 7.6) containing 0.5 mM DTT, 0.2 mM EDTA, 20 mM HEPES, 2.5 mM MgCl 2 , 75 mM NaCl, 0.1 mM Na 3 VO 4 , 50 mM NaF, and 0.1%
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Analysis-Cells
Triton X-100. The protease inhibitors including 1 µg/ml aprotinin, 0.5 µg/ml leupeptin, and 100 µg/ml 4-(2-aminoethyl)benzenesulfonyl fluoride were added to the cell suspension. The cell extracts were gently rotated at 4°C for 30 min. After centrifugation, the pellets were discarded and supernatant protein concentrations were determined by the BCA protein assay kit (Pierce, Rockford, IL). Equal amounts of proteins (20-60 µg/well) were subjected to electrophoresis by 10-12% sodium dodecyl sulfate-polyacrylamide gels. Following electrophoretic transfer of proteins onto polyvinylidene difluoride (PVDF) membranes, they were sequentially hybridized with primary antibody and followed with a horseradish peroxidase-conjugated second antibody (BioRad Co., Hercules, CA). Finally, the protein bands were visualized using the enhanced chemiluminescence detection system (NEN, Boston, MA). To verify equal protein loading and transfer, ERK-2 and p38 were used as the protein loading control.
Transfection-The pOTB7-survivin expression vector was from IMAGE clone (ID 2961114) and was purchased from American Type Culture Collection (ATCC, #MGC-8592).
The piNOSL8-CMV expression vector (41) 
RESULTS
NO Mediates Cytotoxicity, Apoptosis and Decreased Survivin Expression in the Lung
Cancer Cells-As shown in Fig. 1A , SNAP and SNP significantly generated NO in both CL3
and H1299 human lung cancer cells. Concentrations of SNAP (0.4 and 0.8 mM) and SNP (1 and 2 mM) increased the NO production by 7-16 folds (Fig. 1 A) . To determine the involvement of NO in the regulation of cell survival, the cells were exposed to increased Similarly, SNP concentration-dependently induced cytotoxicity in these cell lines (Fig. 1B) .
We further assessed apoptosis from the cells that had been exposed to NO donors.
SNAP-treated H1299 cells were heavily stained with annexin Ⅴ-FITC (early apoptotic cells) that displayed green color (Fig. 1C , the lower right picture) and induced chromatin condensation and nuclear fragmentation (Fig. 2B ), indicating these cells were in the apoptotic stage. The late apoptotic or necrotic cells were stained with annexin Ⅴ-FITC and PI that displayed yellow color (Fig. 1C, the lower right picture) . In contrast, the untreated cells did not stain with fluorochrome (Fig. 1C , the upper right picture). In addition, the apoptosis was measured using the Cell Death Detection ELISA plus kit. As shown in Fig. 1D , the extent of apoptosis was concentration-dependently increased following that exposed to 1-2 mM SNP for 24 h in CL3 cells. Pre-treatment with an NO scavenger cPTIO (42, 43) , significantly reduced SNP-induced apoptosis (Fig. 1D ). In the absence of SNP, the concentration of cPTIO used was without effect on apoptosis in CL3 cells (results not shown).
To examine the expression of survivin in tumor cells, total cellular proteins were extracted and subjected to immunoblot analysis. As shown in Fig. 2A , the tumor cell lines CL3, H1299, A549, and PC12 but not TSGH8301 expressed high levels of survivin protein. The survivin protein was undetectable in the human normal lung fibroblast that was used as a negative control ( Fig. 2A) . To further study the effect of NO donors on the survivin protein expression, cells were treated with SNAP or SNP and subjected to immunofluorescence staining and immunoblot analysis. As shown in Fig. 2B , the intensity of red fluorescence (Cy5) exhibited by survivin was significantly reduced when exposed to 0.4 mM SNAP for 24 h in H1299 cells. Furthermore, SNP reduced the level of survivin protein in both CL3 and H1299 cells in a concentration-dependently manner (Fig. 2C ). ERK-2 protein was used as an internal control in this study. Additionally, the RT-PCR was used to examine the survivin gene expression. As shown in Fig. 2D , both SNAP and SNP decreased the level of survivin gene expression in CL3
cells. However, the protein levels of XIAP and Bcl-2 were not significantly decreased in NO donor-treated CL3 cells (Fig. 2E) 
SNAP Induces Cell Growth Inhibition and Increases the G 2 /M Fractions in CL3 and
H1299 Cells-To examine the effect of NO donors on tumor cell growth, CL3 and H1299
cells were plated at a density of 1 × 10 6 cells per p60 dish and treated with 0-0.8 mM SNAP for 24 h. Cell numbers were counted using a hemocytometer. As shown in Fig. 3A , SNAP inhibited cell growth in a concentration-dependent manner in both CL3 and H1299 cell lines.
To further determine the possible involvement of NO in the regulation of cell cycle, the effect of SNAP on CL3 and H1299 cells were analyzed by flow cytometry. SNAP decreased the G 1 fraction while increased the G 2 /M fraction in CL3 and H1299 cells (Fig. 3B ). To further determine the level of the mitotic progression in SNAP-treated cells, the mitotic index was examined. SNAP concentration-dependently increased the mitotic index of CL3 cells (Fig. 3C ). About 15% of 0.8 mM SNAP-treated CL3 cells were in the mitotic phase, while less than 5% of the untreated cells were in the mitotic phase (Fig. 3C) . We further examined the effect of SNAP on the aphidicolin-synchronized CL3 cells. The fractions of G 2 /M phase were significantly increased at 9 h after terminating the SNAP treatment. Also, SNAP inhibited the cell growth in the synchronized CL3 cells (results not shown).
Over-expression of Survivin by a pOTB7-survivin Vector Reduces NO-induced Growth
Inhibition and Cytotoxicity in CL3 Cells-An expression vector, pOTB7-survivin, and a control vector, pcDNA3.1 were employed for transient transfection in CL3 cells to examine the effect of survivin on NO-induced cell growth inhibition and cell death. As shown in Fig.   4A , the inhibition of cell growth caused by SNP was significantly reversed by the over-expression of survivin. To further investigate the role of survivin in NO-induced cytotoxicity, the pOTB7-survivin transfected-cells were treated with or without SNP (1 mM, 24 h), and the percentage of cell survival was estimated by MTT assay. The pOTB7-survivin vector transfected-cells were more resistant to SNP-mediated cytotoxicity than those control vector transfected-cells (Fig. 4B) .
Inhibition of cdc2/cyclin B1 Enhances NO Donors-induced Cell Death with Decreased
Survivin Expression-Cells were treated with SNAP or SNP and subjected to immunoblot analysis and RT-PCR to study the involvement of cdc2/cyclin B1 in the NO donor-induced inhibition of survivin. CL3 cells were treated with SNP (0-2 mM) for 24 h and p38 MAP kinase was assayed by the immunoblot using the phospho-specific antibody. As shown in Fig. 6A , SNP at 1 and 2 mM significantly increased the level of phospho-p38 protein in a concentration-dependent manner.
To examine whether p38 MAP kinase activation is involved in regulating the expression of survivin induced by NO, the p38 specific inhibitor, SB202190, was used in this study. The inhibition of survivin expression by 2 mM SNP was reversed by pretreatment with SB202190
(20 µM, 2 h) (Fig. 6B ). SB202190 also reversed the level of survivin protein in SNAP-treated CL3 cells (data not shown). In addition, 20 μM SB202190 blocked 0.4 mM SNAP-induced reduction in survivin gene expression in CL3 cells (Fig. 6C) . SB202190 alone did not affect the survival of these cells; however, it significantly reduced the 0.8 mM SNAP-induced cell death (Fig. 6D) .
The iNOS Expression Induces the Cytotoxicity and Inhibits the Level of Survivin in CL3
Cells-To further examine the effect of iNOS expression on the protein level of survivin expression, an expression plasmid, piNOSL8-CMV, and a control vector, pcDNA3.1 were employed for this study. As shown in Fig. 7A , the piNOSL8-CMV-transfected CL3 cells alone did not affect the survival of these cells; however, SB202190 significantly reduced the cell death of the piNOSL8-CMV transfected-cells (Fig. 7B ).
Distinct Expression of Survivin Induced by Anticancer Agents-The CL3 cells were treated
with genistein (30 µM), quercetin (10 µM), sodium arsenite (5 µM) and cisplatin (3 µM) for 24 h, and the whole cell extracts were analyzed for survivin expression using immunoblot assay. The concentrations of anticancer agents used inhibited the cell survival to a similar degree (Fig. 8) . The survivin protein expression was significantly reduced when exposed to 1 mM SNP for 24 h. In contrast, quercetin, arsenite and cisplatin increased the protein level of survivin in CL3 cells. However, the level of survivin protein was not altered by genistein (Fig.   8 ).
DISCUSSION
Inhibitors of the survivin pathway have been intensely investigated for cancer therapy in recent years. The inhibition of survivin would prevent the anti-apoptosis and mitotic progression in tumor cells, providing important strategy in cancer therapy (3) . NO has been shown to trigger apoptosis in a variety of tumor cells (19, 20) . In the present study, we found that exogenously supplied NO donors or endogenous NO generation by iNOS expression inhibited the survivin expression and induced cell death in the human lung carcinoma cells.
Moreover, SNP induced phosphorylation of p38 MAP kinase in CL3 cells. The specific p38
inhibitor, SB202190, was effective in protecting CL3 cells from NO-mediated cell death, and blocked the NO inhibition of survivin expression. The inhibition of survivin expression disrupted anti-apoptosis function, and increased caspase-3 activity (2). p38 MAP kinase has been associated with the induction of apoptosis in numerous cell types and in response to many different cellular stresses (44) (45) (46) . It has been shown that p38 MAP kinase can serve as a mediator of NO-induced, caspase-3-associated apoptosis (29) (30) (31) . Furthermore, another p38
MAP kinase inhibitor, SB203580, has been observed to inhibit the iNOS mRNA expression and the NO production in macrophages (30) . We found that iNOS induction inhibited the survivin protein expression, which was reversed by p38 MAP kinase inhibitor. Thus, our study suggests that NO inhibits survivin expression possibly via the p38 MAP kinase-dependent pathway and induces apoptosis in lung carcinoma cells.
The inhibition of survivin has been related to cell cycle defects (2,13). We found that Furthermore, it has been reported that survivin is required in chromosome segregation and cytokinesis (13, 51, 52) . In addition, survivin has been characterized as a chromosomal passenger protein that interacts with Aurora-B and INCENP (13, 53) . The chromosomal passenger complex has been found to play a crucial role in the execution of cytokinesis (13, 53) . Also, survivin-null cells display abnormal mitotic spindles and failure of cytokinesis (13) . We suggest that the inhibition of the survivin expression by NO may be involved in the inhibition of cytokinesis.
The anticancer drugs or chemicals may induce chemo-resistance during cancer therapy in patients. It has been proposed that survivin may serve as a radio-and chemo-resistance factor (54) . For example, treatments with adriamycin and taxol increased survivin expression in MCF-7 cells (3). In this study, several anticancer agents induced high levels of survivin protein expression. We found that quercetin, arsenite, and cisplatin but not genistein increased the levels of survivin protein in CL3 cells. It has been proposed that the balance between apoptosis (such as p53 pathway) and survival (such as AKT pathway) participates in the pathogenesis of a variety of cancers (55, 56) . The H1299 cell is a p53-null cell line. In this study, we found that NO donors could decrease the survivin expression and induced apoptosis in H1299 cells. Furthermore, SNAP inhibited the cell growth and increased the fractions of G 2 /M phase in H1299 cells. Therefore, we suggest that NO mediates the inhibition of survivin expression through a p53-independent pathway. However, the mechanisms for the increase in survivin level caused by quercetin, arsenite, and cisplatin need further investigation.
In summary, we propose that the expression of survivin appears to be critical for anti-apoptosis and cell cycle progression, and the survivin gene and protein expression in lung carcinoma cells following NO exposure is down-regulated by p38 MAP kinase.
Moreover, NO may inhibit the cdc2/cyclin B1 complex, and may decrease the activation of survivin. Inhibitors of cdc25/cdc2 and p38 MAP kinase indicate the opposite role of cdc2/cyclin B1 and p38 MAP kinase on the regulation of survivin in lung cancer cells (Fig.   9 ). Understanding the mechanisms by which survivin, p38 MAP kinase, and cdc2/cyclin B1 pathways modulate NO-induced cell growth inhibition and apoptosis in cancer cells may contribute to the development of novel therapeutic strategies in such disease states. 
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